September 10, 2003 -- It is with great pleasure that EPI/Moducare® announces that Lorna Vanderhaeghe will extend and expand her role as company spokesperson and consumer education consultant. For the past five years, through her books, website and newsletter, and lectures, Ms. Vanderhaeghe has worked to educate retailers and the public on natural ways to help immune system health. Nancy Cheeseman, North American Sales Manager for EPI (Essential Phytosterolins Inc.), says, “With Lorna’s passion for health and our top-notch product, we make a great team. Her contribution to consumer awareness for Moducare® has been immeasurable, and her increased role in the future will be instrumental in ensuring Moducare® remains the leader in daily immune system health." Over the coming year, look for Lorna to take her wildly popular lectures and retailer seminars ‘on the road’ in Canada and into the United States to promote the health benefits of Moducare® and continue the growth of the brand.
Super-powered spokeswoman has mass appeal
About her work with EPI, Lorna says, "I am thrilled to extend my role as company spokesperson into the future. I’ve been doing this for over five years now and yet I am still eager to educate consumers on the life changing benefits of Moducare®. The consumer testimonials and clinical research supporting the use of Moducare® is overwhelming, and in line with my philosophy of providing people with health knowledge so they can achieve optimal wellness in their lives."
Lorna is a medical journalist, researching and writing on the subject of nutritional medicine for over 20 years. She has a Bachelor of Science in Biochemistry and is currently earning her Masters degree in Nutrition. Her list of accomplishments includes, past Editor-in-Chief of Healthy Living Guide magazine and Senior Editor of the Encyclopedia of Natural Healing. She is co-author of the award-winning, best-selling book, The Immune System Cure as well as Healthy Immunity, Scientifically Proven Natural Treatments for Conditions from A-Z, Healthy Fats for Life and co-author of No More HRT: Menopause, Treat the Cause. Currently, she is an Associate Editor for both Total Health magazine in the United States and alive magazine in Canada.
Award-winning leader in immune system health
Moducare® is a patented blend of plant sterols and sterolins, clinically proven to help regulate the immune system, 'upregulating' when the immune system is depressed and 'downregulating' when the immune system is overactive. Numerous double-blind, placebo controlled studies have shown Moducare®'s specific ratio of sterols to sterolins is highly effective for immune system support. Since hitting the North American marketplace five years ago, Moducare® has received numerous industry awards. Most recently, it was honoured with the 2002 Gold Vity Award from Vitamin Retailer for 'Best Immune Supplement' and the 2002 Product Merit Award from Nutrition Business Journal. In addition to its original formula, Moducare® now comes in Chewable Grape Flavour. Plus, with the launch of this new product, the entire Moducare line was redesigned with bright, bold new packaging. In 2003-2004, EPI has plans to extend the Moducare® brand even further.
Essential Phytosterolins Inc (EPI) is the manufacturer of Moducare®. EPI is dedicated to providing the highest quality health products and to achieving excellence in health care through an ongoing commitment to research and education. EPI subscribes to the philosophy that nature can help humankind find cures for the most challenging diseases and that responsible, ethical science is the key to unlocking these secrets.
EPI was formed in 1998 when its parent company Essential Sterolin Products (ESP) in South Africa began distribution of Moducare® in North America. Since 1968, under the direction of R W Liebenberg, ESP has been committed to the research and development of Moducare® and to its worldwide distribution. Moducare® is the only clinically tested plant sterol/sterolin product proven to be effective in immune modulation. Research, including placebo-controlled, double-blind studies, has been published in international medical journals. EPI, in partnership with ESP continues to sponsor research programs.
- 30 -